Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Mycophenolate mofetil potentiates antiherpesvirus activity of aciclovir

Jan. 8, 1999

FDA clears new product for preventing kidney transplant rejection

Jan. 5, 1999

New indications for Prograf scheduled for FDA advisory committee review

Dec. 30, 1998

Ono-4057 useful in organ transplants according to results presented at Japanese congress

Dec. 29, 1998

Hyseq presents gene product with potential application to vaccine development

Dec. 28, 1998

Disposition of L-732351, a semisynthetic macrolide immunosuppressant, in animals

Dec. 23, 1998

FDA approves first Lyme disease vaccine

Dec. 22, 1998

Abgenix completes phase II clinical trial in GVHD

Dec. 22, 1998

Abgenix and RCT enter CD45RB antibody collaboration

Dec. 21, 1998

Novartis updates status of immunosuppressive agent

Dec. 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...